These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 17936633

  • 1. Small P-gp modulating molecules: SAR studies on tetrahydroisoquinoline derivatives.
    Colabufo NA, Berardi F, Cantore M, Perrone MG, Contino M, Inglese C, Niso M, Perrone R, Azzariti A, Simone GM, Porcelli L, Paradiso A.
    Bioorg Med Chem; 2008 Jan 01; 16(1):362-73. PubMed ID: 17936633
    [Abstract] [Full Text] [Related]

  • 2. 4-Biphenyl and 2-naphthyl substituted 6,7-dimethoxytetrahydroisoquinoline derivatives as potent P-gp modulators.
    Colabufo NA, Berardi F, Cantore M, Perrone MG, Contino M, Inglese C, Niso M, Perrone R, Azzariti A, Simone GM, Paradiso A.
    Bioorg Med Chem; 2008 Apr 01; 16(7):3732-43. PubMed ID: 18276145
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of P-glycoprotein function by XR9576 in a solid tumour model can restore anticancer drug efficacy.
    Walker J, Martin C, Callaghan R.
    Eur J Cancer; 2004 Mar 01; 40(4):594-605. PubMed ID: 14962729
    [Abstract] [Full Text] [Related]

  • 4. 1-Cyclohexyl-4-(4-arylcyclohexyl)piperazines: Mixed σ and human Δ(8)-Δ(7) sterol isomerase ligands with antiproliferative and P-glycoprotein inhibitory activity.
    Abate C, Niso M, Contino M, Colabufo NA, Ferorelli S, Perrone R, Berardi F.
    ChemMedChem; 2011 Jan 03; 6(1):73-80. PubMed ID: 21069657
    [Abstract] [Full Text] [Related]

  • 5. Substituted tetrahydroisoquinoline compound B3 inhibited P-glycoprotein-mediated multidrug resistance in-vitro and in-vivo.
    Fang W, Li Y, Cai Y, Kang K, Yan F, Liu G, Huang W.
    J Pharm Pharmacol; 2007 Dec 03; 59(12):1649-55. PubMed ID: 18053326
    [Abstract] [Full Text] [Related]

  • 6. Increased anti-P-glycoprotein activity of baicalein by alkylation on the A ring.
    Lee Y, Yeo H, Liu SH, Jiang Z, Savizky RM, Austin DJ, Cheng YC.
    J Med Chem; 2004 Oct 21; 47(22):5555-66. PubMed ID: 15481991
    [Abstract] [Full Text] [Related]

  • 7. Interactions of the multidrug resistance modulators tariquidar and elacridar and their analogues with P-glycoprotein.
    Pajeva IK, Sterz K, Christlieb M, Steggemann K, Marighetti F, Wiese M.
    ChemMedChem; 2013 Oct 21; 8(10):1701-13. PubMed ID: 23943604
    [Abstract] [Full Text] [Related]

  • 8. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
    Wang TX, Yang XH.
    Yao Xue Xue Bao; 2008 May 21; 43(5):461-6. PubMed ID: 18717331
    [Abstract] [Full Text] [Related]

  • 9. Design and syntheses of permethyl ningalin B analogues: potent multidrug resistance (MDR) reversal agents of cancer cells.
    Zhang PY, Wong IL, Yan CS, Zhang XY, Jiang T, Chow LM, Wan SB.
    J Med Chem; 2010 Jul 22; 53(14):5108-20. PubMed ID: 20560605
    [Abstract] [Full Text] [Related]

  • 10. Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells.
    Li X, Sun B, Zhu CJ, Yuan HQ, Shi YQ, Gao J, Li SJ, Lou HX.
    Toxicol In Vitro; 2009 Feb 22; 23(1):29-36. PubMed ID: 18938236
    [Abstract] [Full Text] [Related]

  • 11. Phenylsulfonylfuroxans as modulators of multidrug-resistance-associated protein-1 and P-glycoprotein.
    Fruttero R, Crosetti M, Chegaev K, Guglielmo S, Gasco A, Berardi F, Niso M, Perrone R, Panaro MA, Colabufo NA.
    J Med Chem; 2010 Aug 12; 53(15):5467-75. PubMed ID: 20684594
    [Abstract] [Full Text] [Related]

  • 12. Arylmethyloxyphenyl derivatives: small molecules displaying P-glycoprotein inhibition.
    Colabufo NA, Berardi F, Perrone R, Rapposelli S, Digiacomo M, Balsamo A.
    J Med Chem; 2006 Nov 02; 49(22):6607-13. PubMed ID: 17064079
    [Abstract] [Full Text] [Related]

  • 13. Novel multidrug resistance reversal agents.
    Berger D, Citarella R, Dutia M, Greenberger L, Hallett W, Paul R, Powell D.
    J Med Chem; 1999 Jun 17; 42(12):2145-61. PubMed ID: 10377220
    [Abstract] [Full Text] [Related]

  • 14. Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer.
    Wong HL, Bendayan R, Rauth AM, Wu XY.
    J Control Release; 2006 Dec 01; 116(3):275-84. PubMed ID: 17097178
    [Abstract] [Full Text] [Related]

  • 15. CJY, an isoflavone, reverses P-glycoprotein-mediated multidrug-resistance in doxorubicin-resistant human myelogenous leukaemia (K562/DOX) cells.
    Ji BS, He L.
    J Pharm Pharmacol; 2007 Jul 01; 59(7):1011-5. PubMed ID: 17637197
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of anticancer effects of newly synthesized dihydropyridine derivatives in comparison to verapamil and doxorubicin on T47D parental and resistant cell lines in vitro.
    Bazargan L, Fouladdel S, Shafiee A, Amini M, Ghaffari SM, Azizi E.
    Cell Biol Toxicol; 2008 Apr 01; 24(2):165-74. PubMed ID: 17805981
    [Abstract] [Full Text] [Related]

  • 17. Long-circulating PEG-PE micelles co-loaded with paclitaxel and elacridar (GG918) overcome multidrug resistance.
    Sarisozen C, Vural I, Levchenko T, Hincal AA, Torchilin VP.
    Drug Deliv; 2012 Nov 01; 19(8):363-70. PubMed ID: 23030458
    [Abstract] [Full Text] [Related]

  • 18. The acridonecarboxamide GF120918 potently reverses P-glycoprotein-mediated resistance in human sarcoma MES-Dx5 cells.
    Traunecker HC, Stevens MC, Kerr DJ, Ferry DR.
    Br J Cancer; 1999 Nov 01; 81(6):942-51. PubMed ID: 10576649
    [Abstract] [Full Text] [Related]

  • 19. Reversal effect of substituted 1,3-dimethyl-1H-quinoxalin-2-ones on multidrug resistance in adriamycin-resistant K562/A02 cells.
    Sun LR, Li X, Cheng YN, Yuan HY, Chen MH, Tang W, Ward SG, Qu XJ.
    Biomed Pharmacother; 2009 Mar 01; 63(3):202-8. PubMed ID: 18818047
    [Abstract] [Full Text] [Related]

  • 20. Levistolide A overcomes P-glycoprotein-mediated drug resistance in human breast carcinoma cells.
    Chen F, Wang T, Wang J, Wang ZQ, Qian M.
    Acta Pharmacol Sin; 2008 Apr 01; 29(4):458-64. PubMed ID: 18358092
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.